HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- High hopes, realistic expectations drive bevacizumab treatment
-
- ACE inhibitors may be linked to breast cancer recurrence
- Better sleep hygiene may improve neurocognitive function of childhood cancer survivors
- Malpractice case against several physicians reveals missed diagnosis
- Omega-3 fatty acid may be linked to prostate cancer risk
- Positron emission mammography shows promise in breast cancer
- Elderly woman with prior breast cancer presents with growing skin lesion Ramya Varadarajan, MD
- WHO: Noncommunicable diseases on the rise globally
- The ironies of new therapies William Wood, MD
-
- Alcohol consumption linked to increased cancer risk
- AMLCG-99: Allogeneic transplantation preferred post-remission therapy for high-risk AML
- Apixaban reduced risk for stroke, embolism in patients ineligible for vitamin K antagonist
- Decitabine improved PFS, AML transformation in older patients with myelodysplastic syndrome
- High mitotic rate associated with poorer survival in primary melanoma
- Radioactive iodine therapy associated with increased second malignancies in low-risk thyroid cancer
- Serum alpha-carotene inversely associated with death from cancer, all-causes
- Use of advanced radiation influenced by Medicare reimbursement
-
- Uterine, prostate cancers may be linked on genetic level
- VEGFA gene amplification associated with poor prognosis in osteosarcoma
- Exercise reduced risk for colon polyps
- In “Year of Melanoma,” meeting offers information, innovation
- Minimally invasive colorectal resection more likely for wealthier patients
- Oncolytic viruses targeted, killed pancreatic cancer stem cells
- Statins reduced risk in patients with SMAD4-expressing colorectal tumors
- Thymidylate synthase genotyping guides therapy in patients with rectal adenocarcinoma Paul Morales, PharmD
-